We are live on ! Find out more
HP

Harbourvest Partners Portfolio holdings

AUM $101M
1-Year Est. Return 38.13%
This Fund
S&P 500
This Quarter Est. Return
+4.5%
1 Year Est. Return
-38.13%
3 Year Est. Return
-6.18%
5 Year Est. Return
-50.73%
10 Year Est. Return
+34.53%
AUM
$111M
AUM Growth
+$31.4M
Cap. Flow
+$30.1M
Cap. Flow %
27.21%
Top 10 Hldgs %
89.23%
Holding
35
New
14
Increased
1
Reduced
–
Closed
9

Top Buys

Rank Stock Value
1
RUBY
Rubius Therapeutics, Inc
RUBY
+$22.6M
2
SNAP icon
Snap
SNAP
+$4.52M
3
COUP
Coupa Software Incorporated
COUP
+$4.44M
4
ZUO
Zuora, Inc.
ZUO
+$4.37M
5
YEXT icon
Yext
YEXT
+$2.63M

Top Sells

Rank Stock Value
1
MYOK
MyoKardia, Inc. Common Stock
MYOK
+$8.05M
2
RDFN
Redfin
RDFN
+$3.4M
3
FSCT
ForeScout Technologies, Inc. Common Stock
FSCT
+$2.09M
4
ALRM icon
Alarm.com
ALRM
+$1.2M
5
TSLA icon
Tesla
TSLA
+$1.09M

Sector Composition

Rank Sector Weight
1 Healthcare 46.46%
2 Technology 13.13%
3 Financials 8.7%
4 Communication Services 7.75%
5 Consumer Discretionary 4.7%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
RUBY
1
DELISTED
Rubius Therapeutics, Inc
RUBY
$23.7M 21.41%
+986,878
New +$22.6M
EVLO
2
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
$21.5M 19.42%
88,175
– –
FNJN
3
DELISTED
Finjan Holdings, Inc.
FNJN
$18.5M 16.77%
4,303,435
– –
HAPN
4
Happen Inc
HAPN
$2.19B
$9.62M 8.7%
496,041
– –
SNAP icon
5
Snap
SNAP
$8.02B
$8.57M 7.75%
1,010,572
+389,098
+63% +$4.52M
COUP
6
DELISTED
Coupa Software Incorporated
COUP
$5.06M 4.58%
+63,988
New +$4.44M
ZUO
7
DELISTED
Zuora, Inc.
ZUO
$3.79M 3.42%
+163,894
New +$4.37M
SFIX
8
Stitch Fix
SFIX
$563M
$2.91M 2.63%
+66,571
New +$2.43M
YEXT icon
9
Yext
YEXT
$564M
$2.73M 2.47%
+115,147
New +$2.63M
PRTS icon
10
CarParts.com
PRTS
$42.4M
$2.29M 2.07%
147,688
– –
INOV
11
DELISTED
Inovalon Holdings, Inc. Class A Common Stock
INOV
$2.29M 2.07%
227,614
– –
CTMX icon
12
CytomX Therapeutics
CTMX
$701M
$1.43M 1.29%
79,193
– –
VYGR icon
13
Voyager Therapeutics
VYGR
$184M
$1.38M 1.24%
+72,726
New +$1.4M
KA
14
DELISTED
Kineta, Inc. Common Stock
KA
$1.06M 0.96%
3,147
– –
KALA icon
15
KALA BIO
KALA
$12.3M
$955K 0.86%
+40
New +$1.22M
CSLT
16
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$918K 0.83%
+349,070
New +$1.23M
TBRG
17
DELISTED
TruBridge
TBRG
$917K 0.83%
+34,141
New +$999K
MITL
18
DELISTED
Mitel Networks Corporation
MITL
$603K 0.55%
+54,756
New +$602K
RPD icon
19
Rapid7
RPD
$642M
$595K 0.54%
+16,125
New +$541K
TRVN
20
DELISTED
Trevena, Inc.
TRVN
$482K 0.44%
374
– –
RUN icon
21
Sunrun
RUN
$2.3B
$422K 0.38%
+34,800
New +$482K
HIVE
22
DELISTED
Aerohive Networks
HIVE
$410K 0.37%
+99,609
New +$415K
SGU icon
23
Star Group
SGU
$415M
$160K 0.14%
16,381
– –
YUMA
24
DELISTED
Yuma Energy Inc
YUMA
$129K 0.12%
21,498
– –
METC icon
25
Ramaco Resources Class A
METC
$637M
$88K 0.08%
+12,188
New +$85.5K
1
2

Similar funds

VCM
Vines Capital Management Monroe, Louisiana $101M AUM
TCI
Triveni Capital Investments Stamford, Connecticut $101M AUM
RPC
Royal Palms Capital Whitefish, Montana $101M AUM
XC
XY Capital Central, Hong Kong $101M AUM 1.14% 1-Year Est. Return
AWA
Ark Wealth Advisors Yorba Linda, California $101M AUM
HWM
Hobbs Wealth Management Zionsville, Indiana $101M AUM 22.3% 1-Year Est. Return
CG
Column Group San Francisco, California $101M AUM 290.34% 1-Year Est. Return
ROP
Rule One Partners Moreland, Georgia $101M AUM 6.3% 1-Year Est. Return

Harbourvest Partners's Q3 2018 Portfolio in Review

As of Q3 2018, Harbourvest Partners held 35 positions worth $111M, up 40% from $79.2M the previous quarter. Its ten largest holdings account for 89% of the portfolio.

Harbourvest Partners deployed $30.1M of net new capital in Q3 2018, opening 14 new positions and adding to 1 existing holding. Its largest new stake was Rubius Therapeutics, Inc: 986,878 shares worth $23.7M.

By sector, the portfolio is most concentrated in Healthcare at 46% of assets, up from 41% a quarter earlier, followed by Technology and Financials.

On the sell side, the most notable exit was MyoKardia, Inc. Common Stock, an estimated $8.05M sold.

  • Harbourvest Partners's largest Q3 2018 buy was Rubius Therapeutics, Inc: 986,878 shares worth $23.7M.
  • Harbourvest Partners added most to Snap in Q3 2018, an estimated $4.52M increase.
  • Harbourvest Partners fully exited MyoKardia, Inc. Common Stock in Q3 2018, selling an estimated $8.05M.
  • Harbourvest Partners's ten largest holdings make up 89% of its $111M portfolio in Q3 2018.
  • Harbourvest Partners opened 14 new positions and closed 9 in Q3 2018.
  • Harbourvest Partners's portfolio value rose 40% quarter-over-quarter to $111M.

Based on Harbourvest Partners's 13F filing for Q3 2018, filed 14 Nov 2018.